Group 1 - In the first half of the year, 82.97% of the 8267 comparable mixed funds saw an increase in net value, with 6859 funds rising and 1398 funds declining [1] - Six mixed funds achieved a growth rate exceeding 70%, with the top three being theme products focused on the Beijing Stock Exchange [1][2] - The top-performing fund, China CITIC Bank's Beijing Stock Exchange Selected Two-Year Open Mixed A, recorded a growth of 82.45% and a cumulative net value of 2.3271 yuan since its establishment [1][5] Group 2 - The China CITIC Bank's Beijing Stock Exchange Selected Two-Year Open Mixed Fund A and C are primarily invested in companies that meet the "specialized, refined, unique, and innovative" criteria in various sectors, including medical beauty and automotive parts [2] - The fund manager, Gu Xinfeng, has extensive experience in investment research and management within the industry [2] - Other funds with over 70% growth include Changcheng Medical Industry Selected Mixed Fund A and C, and Bank of China Hong Kong Stock Connect Medical Mixed Fund A, with growth rates of 75.18%, 74.73%, and 70.08% respectively [2][3] Group 3 - The Changcheng Medical Industry Selected Mixed Fund A and C focused on innovative drug sectors, investing in companies with disruptive innovation and those that have commercialized their products [3] - The fund manager, Liang Furui, has a background in medical research and has been with Changcheng Fund Management since 2019 [3] - Four funds from Caitong Fund Management Company were among the top ten funds with the largest declines, each dropping over 16% [3][4]
上半年83%混基正收益 华夏北交所精选两年定开涨72%
Zhong Guo Jing Ji Wang·2025-07-03 23:24